Topline
The Food and Drug Administration on Tuesday approved Ozampic for the treatment of chronic disease patients, indicating the latest authorized use of Novo Nordsesk for popular drugs that for diabetes and weight loss. Known.
Regulators have approved drugs as a treatment for weight loss, type 2 diabetes and reduction 8 speaking about the day about living [+]
Key facts
FDA Said Ozampic can be used to reduce the risk of kidney disease, kidney failure and death from cardiovascular cases in patients with type 2 diabetes and kidney disease.
The agency cited the results of the late -phase trial of Novo Nordesk, which Reported In March 2024 – Type 2 diabetes trials of more than 3,500 people – Ozampic reduced the risk of developing kidney disease and kidney or cardiovascular complications compared to Placebo.
Novo Nordesk said patients using ozampic also reported kidney reduction rates.
European Union’s Health Regulators Said In December that Nova Nordsesk may increase its label for Ozampic, the same study cited that the drug in this drug is to reduce the risk of having chronic diabetes in diabetes adults. Can be added.
Forbus get breaking news text alerts: We are launching text messages alerts so you will always know the biggest stories that make up the headlines. (201) Text “Alerts” on 335-0739 or sign up Here.
Wonderful reality
Centers for control and prevention of diseases Estimated One of the three adults with diabetes contains chronic kidney disease. The agency said that type 1 and type 2 diabetes can cause kidney disease, as diabetes can reduce how kidney waste can filter. According to the CDC, diabetics also give rise to hypertension, which can cause kidney damage.
For whom Ozimpak has been approved?
The FDA has approved Ozampic for type 2 diabetes, but it is also known for weight loss LA label of label. The agency has given Novo Nordesk’s Vigovo – which is the same active ingredient for weight loss, like semuglotide, ozampic. Jeopardy Cardiovascular events like heart attacks or strokes.
Key background
More studies have been studied in recent years about the benefits of medications like Novo Nordesk and Vigovo, which belong to a class of medicines called GLP-1 agonists. These medicines imitate the work of the gut hormone in managing blood sugar and appetite, which approves them for the treatment of diabetes and obesity. After the FDA, Eli Lily’s weight loss drug Zipbound has also been approved for the treatment of obesity as well as sleeplessness. Said In the phase phase case, the incidence of phase in the phase of the drug decreased “significantly in terms of statistics”. Some studies suggest that GLP-1 can be used for treatment Error the use of alcohol And relieve symptoms in mood, academic function and patients with Parkinson’s, Alzheimer’s, dementia, bipolar disorders and anxiety. In recent years, further studies have been studied about the benefits of medicines like Novo Nordesk’s Ozampic and Vigo, which belong to the class. Medicines known as GLP-1 agonists. These medicines imitate the work of the gut hormone in managing blood sugar and appetite, which approves them for the treatment of diabetes and obesity. After the FDA, Eli Lily’s weight loss drug Zipbound has also been approved for the treatment of obesity as well as sleeplessness. Said In the phase phase case, the incidence of phase in the phase of the drug decreased “significantly in terms of statistics”. Some studies suggest that GLP-1 can be used for treatment Error the use of alcohol And promote symptoms in mood, academic function and patients with Parkinson’s, Alzheimer’s, dementia, bipolar disorders and anxiety.
Read more
